---
$id: https://graph.org.ai/products/commodity/51142430
$type: Product
source: UNSPSC
code: "51142430"
title: "Frovatriptan succinate hydrate"
class: "51142400"
classTitle: "Drugs used for vascular and migraine headaches"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Frovatriptan succinate hydrate

**UNSPSC Code**: 51142430
**Class**: [Drugs used for vascular and migraine headaches](Drugs used for vascular and migraine headaches.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a serotonin agonist with the molecular formula C14H17N3O.C4H6O4.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D28J6W18HY, chemically known as butanedioic acid, compd. with (r)-2,3,4,9-tetrahydro-3-(methylamino)-1h-carbazole-6-carboxamide (1:1), monohydrate, but more generally known as frovatriptan succinate hydrate, which bears US NIH Compound Identifier 152943. European Medicines Agency schedules frovatriptan succinate hydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07817MIG. Most nations, for tariff purposes, schedule frovatriptan succinate hydrate under HS 29339990. SMILES: CN[C@@H]1CCC2C(C3CC(CCC3[NH]2)C(=O)N)C1.C(CC(=O)O)C(=O)O.O.

